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Scope of Research
The research interests of this laboratory include the development of advanced 
molecular transformation, total synthesis of biologically active products, and molecu-
lar recognition. Programs are active in the following areas: 1) asymmetric alkylation 
of carbonyl compounds based on “memory of chirality”, 2) organocatalysis for fine 
organic syntheses, 3) synthesis of unusual amino acids and nitrogen heterocycles, 4) 
regioselective functionalization of carbohydrates, and 5) the structural and functional 
investigation of heterochiral oligomers.
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Topics
An Unconventional Retrosynthesis of Acylated 
Natural Glycosides: Final-stage Site-selective 
Acylation of Unprotected Glycosides
Several hundreds of acylated glycosides such as pheny-
lethanoid glycosides and ellagitannins exist in nature. Some 
of them show potent biological activities including antivi-
rus, antitumor, and antiallergic activities, and have attracted 
interest for synthesis. Multifidosides A-C, isolated from 
whole plants used in traditional Chinese medicine, possess 
a p-coumaroyl group at C(4)–OH of the glucopyranose 
moiety. Properly protected precursor 3 with free C(4)–OH 
is a rational precursor for the synthesis of multifidoside B 
(1) based on the conventional protection/deprotection strat-
egy. In contrast, we propose an unconventional strategy 
based on final-stage site-selective acylation: the p-couma-
royl group can be introduced directly onto the C(4)–OH of 
the unprotected precursor 2 at the final step of total syn-
thesis. The expected advantages of the proposed strategy 
would be: 1) streamlining for fewer steps for the total syn-
thesis and 2) avoidance of the risks of the undesired side 
reactions during the removal of the protecting groups (PGs) 
at a later stage of the conventional synthetic scheme.
Unprotected precursor 2 was readily prepared by a thir-
teen-step transformation from commercially available 4, 
in which an intramolecular asymmetric aldol reaction of 5 
catalyzed by organocatalyst 6 was performed as a key step. 
As we expected, acylation of 2 promoted by our originally 
developed organocatalyst 9 took place at the intrinsically 
less reactive C(4)–OH of the glucopyranose substructure 
even in the presence of two primary hydroxy groups. Thus, 
multifidoside C was obtained in one step from the unpro-
tected precursor 2 by the removal of the TES group during 
the work-up process. Notably, the synthetic route has a 
one-step conversion from a natural glycoside into another 
natural glycoside, since 2 is also a naturally occurring gly-
coside named (2R,3S)-wallichoside. Similarly, the first total 
syntheses of multifidosides A and C have been achieved 
by final-stage site-selective acylation of the precursor 
natural glycosides, (2S,3S)-wallichoside and pteroside B, 
respectively. Considering the predictability and reliability 
of the site-selective acylation promoted by catalyst 9, the 
proposed strategy could provide a general synthetic route 
to 4-O-acylglycosides. 
Asymmetric α−Arylation of Amino Acid 
Derivatives by Intramolecular Aryl Migration 
of Ester Enolates via Memory of Chirality
Asymmetric α−arylation of amino acids has been a 
challenge in current organic synthesis. We have devel-
oped a method for asymmetric α−arylation of amino acid 
derivatives via intramolecular aryl migration (Clayden 
rearrangement) of chiral enolates generated from amino 
acid esters, based on the protocol of memory of chirality. 
The reaction took place through inversion of configura-
tion via chiral enolate intermediate A, whose racemization 
barrier was ~15 kcal/mol at −78 °C. The half-life of race-
mization of the axially chiral enolate was estimated to be 
~5 min at −60 °C (reaction temperature). This method 
provides chiral hydantoins with aryl-substituted tetrasubsi-
tuted carbon, potentially useful chiral building blocks in the 
field of medicinal chemistry, and are structural equivalents 
to amino acids with aryl-substituted tetrasubsituted carbon.
